FELIX Trademark

Trademark Overview


On Friday, June 23, 2023, a trademark application was filed for FELIX with the United States Patent and Trademark Office. The USPTO has given the FELIX trademark a serial number of 98057163. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, July 1, 2024. This trademark is owned by Fasikl Inc.. The FELIX trademark is filed in the Medical Instrument Products category with the following description:

Medical device, namely, a device used for treatment of individuals with tremors
felix

General Information


Serial Number98057163
Word MarkFELIX
Filing DateFriday, June 23, 2023
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, July 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical device, namely, a device used for treatment of individuals with tremors

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, August 2, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFasikl Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMoran, TX 764643223

Trademark Events


Event DateEvent Description
Tuesday, June 27, 2023NEW APPLICATION ENTERED
Wednesday, August 2, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 11, 2024ASSIGNED TO EXAMINER
Monday, July 1, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, July 1, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Friday, March 15, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 15, 2024NON-FINAL ACTION WRITTEN
Friday, March 15, 2024NON-FINAL ACTION E-MAILED